TrialAnnals of the rheumatic diseases2021

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.

René Westhovens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.